# K072000: Aplio XG Diagnostic Ultrasound System, Model Ssa-790A Version 2.0

- Pathway: 510(k) (Traditional)
- Applicant: Toshiba America Medical Systems, In.C
- Decided: Jul 30, 2007 after 7 days
- Product code: IYN (System, Imaging, Pulsed Doppler, Ultrasonic)
- Device class: 2
- Regulation: 21 CFR 892.1550
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K894632 (1989). 49 ancestors in all.
203 later devices descend from it; 4 cite it directly.
0 of 253 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K063130: Aplio XG Diagnostic Ultrasound System, Model Ssa-790A, Version 1.0, Toshibamedical Systems Corporation (2006) Summary page 1.
- K052410: Acuson Sequoia Ultrasound System, Siemens Medical Solutions USA, Inc. (2005) Summary page 1.

## Most influential descendants
- K080160: Aplio Artida, Model SSH-880CV Diagnostic Ultrasound System (2008), 181 descendants of its own
- K081065: Aplio XG Diagnostic Ultrasound System, Model Ssa - 790A, Version 2.2 (2008), 118 descendants of its own
- K082119: Aplio XG Diagnostic Ultrasound System, Model Ssa - 790A Version 3.0 (2008), 116 descendants of its own
- K090158: Aplio Artida V2.0 SSH-880CV (2009), 98 descendants of its own
- K110870: Aplio Diagnostic Ultrasound System; Aplio Diagnostic Ultrasound System; Aplio Diagnostic Ultrasound System (2011), 89 descendants of its own

## Indications for use
The Aplio XG is intended to be used for the following type of studies; fetal, abdominal, intraoperative, pediatric, small organs, neonatal cephalic, adult cephalic, cardiac, transrectal, transvaginal, transesophageal, peripheral vascular and musculo-skeletal (both conventional and superficial).

Source page: https://510kreport.com/device/K072000
Methodology: https://510kreport.com/methodology